Craig Millian
Chief Executive Officer chez HLS THERAPEUTICS INC.
Fortune : 64 616 $ au 31/03/2024
Profil
Craig Millian is currently the Chief Executive Officer & Director at HLS Therapeutics, Inc. Prior to this, he was the Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc. from 2021 to 2023.
He was also the Senior Vice President-Neurology & Immunology at EMD Serono, Inc. from 2016 to 2018.
Before that, he worked as the Vice President-Commercial at Vertex Pharmaceuticals, Inc. Mr. Millian has an undergraduate degree from the University of Pennsylvania and an MBA from New York University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/02/2023 | 900 ( 0,01% ) | 35 316 $ | 31/03/2024 | |
HLS THERAPEUTICS, INC.
0,03% | 16/11/2023 | 10 000 ( 0,03% ) | 29 300 $ | 31/03/2024 |
Postes actifs de Craig Millian
| Sociétés | Poste | Début |
|---|---|---|
| HLS THERAPEUTICS INC. | Chief Executive Officer | 01/05/2023 |
Anciens postes connus de Craig Millian
| Sociétés | Poste | Fin |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Chief Operating Officer | 14/04/2023 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01/12/2018 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
Formation de Craig Millian
| University of Pennsylvania | Undergraduate Degree |
| New York University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| HLS THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
| Corbus Pharmaceuticals Holdings, Inc. |
